The evolving landscape of cardiometabolic diseases.
作者信息
Eroglu Tolga, Capone Federico, Schiattarella Gabriele G
机构信息
Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité -Universitätsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité -Universitätsmedizin Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Department of Medicine (DIMED), Unit of Internal Medicine III, Padua University Hospital, University of Padua, Padova, Italy; Department of Biomedical Sciences, University of Padova, Padova, Italy.
出版信息
EBioMedicine. 2024 Nov;109:105447. doi: 10.1016/j.ebiom.2024.105447. Epub 2024 Nov 4.
Abstract
摘要
相似文献
1
The evolving landscape of cardiometabolic diseases.心血管代谢疾病的不断演变态势。
EBioMedicine. 2024 Nov;109:105447. doi: 10.1016/j.ebiom.2024.105447. Epub 2024 Nov 4.
2
The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009-2021.2009 - 2021年中国心血管代谢疾病药物临床试验的变化态势
Diabetol Metab Syndr. 2023 Apr 1;15(1):66. doi: 10.1186/s13098-023-01043-8.
3
Harnessing NAD Metabolism as Therapy for Cardiometabolic Diseases.利用 NAD 代谢作为治疗心脏代谢疾病的方法。
Curr Heart Fail Rep. 2022 Aug;19(4):157-169. doi: 10.1007/s11897-022-00550-5. Epub 2022 May 13.
4
Landscape of cardiometabolic risk factors in Chinese population: a narrative review.中国人群中心血管代谢危险因素的现状：叙述性综述。
Cardiovasc Diabetol. 2022 Jun 21;21(1):113. doi: 10.1186/s12933-022-01551-3.
5
Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes.妊娠对心脏代谢疾病风险的影响：子痫前期和妊娠期糖尿病。
Am J Physiol Cell Physiol. 2024 Sep 1;327(3):C646-C660. doi: 10.1152/ajpcell.00293.2024. Epub 2024 Jul 16.
6
PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker.PCSK9：心脏代谢衰老中的新兴参与者及其作为治疗靶点和生物标志物的潜力。
Geroscience. 2024 Feb;46(1):257-263. doi: 10.1007/s11357-023-01003-0. Epub 2023 Dec 18.
7
The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.人类心脏代谢综合征肥胖ZSF1大鼠模型中不断演变的系统生物标志物环境：模型特征及生长分化因子15的心脏保护作用
PLoS One. 2020 Aug 17;15(8):e0231234. doi: 10.1371/journal.pone.0231234. eCollection 2020.
8
Pregnancy Reveals Evolving Risk for Cardiometabolic Disease in Women.怀孕揭示了女性心血管代谢疾病风险的演变。
J Obstet Gynecol Neonatal Nurs. 2016 May-Jun;45(3):413-25. doi: 10.1016/j.jogn.2016.02.004. Epub 2016 Mar 14.
9
Chrononutrition and Cardiometabolic Health: An Overview of Epidemiological Evidence and Key Future Research Directions.时间营养与心脏代谢健康：流行病学证据概述及未来主要研究方向。
Nutrients. 2024 Jul 19;16(14):2332. doi: 10.3390/nu16142332.
10
A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review.糖尿病中表观遗传谱和染色质修饰疗法的最新进展：综述
Curr Med Chem. 2023;30(18):2020-2038. doi: 10.2174/0929867329666220802090446.
引用本文的文献
1
Evaluating the Impact of Family History and Polygenic Risk Scores on Cardiometabolic Disease Risk.评估家族史和多基因风险评分对心脏代谢疾病风险的影响。
Res Sq. 2025 Aug 1:rs.3.rs-7142452. doi: 10.21203/rs.3.rs-7142452/v1.
2
Effectiveness of different intervention designs for improving physical activity in adults with cardiometabolic conditions over time: a systematic review and network meta-analysis of randomised controlled trials.不同干预设计对改善患有心脏代谢疾病的成年人身体活动水平的长期效果：一项随机对照试验的系统评价和网状荟萃分析
BMC Med. 2025 Jul 22;23(1):437. doi: 10.1186/s12916-025-04240-6.
3
Academic Hegemony and Monitoring of Shared Power in Community-Engaged Research Trials: The Mid-Atlantic Center for Cardiometabolic Health Equity, 2023-2024.社区参与研究试验中的学术霸权与共享权力监督：大西洋中部心脏代谢健康公平中心，2023 - 2024年
Am J Public Health. 2025 Jul;115(S2):S164-S173. doi: 10.2105/AJPH.2025.308188.
4
Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications.整合代谢组学和基因组学揭示2型糖尿病及其心血管并发症的分子特征。
Cardiovasc Diabetol. 2025 Apr 16;24(1):166. doi: 10.1186/s12933-025-02718-4.
本文引用的文献
1
National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022: a pooled analysis of 507 population-based surveys with 5·7 million participants.2000 年至 2022 年成年人身体活动不足的全球、区域和国家趋势：来自 507 项基于人群的调查的合并分析，涉及 570 万参与者。
Lancet Glob Health. 2024 Aug;12(8):e1232-e1243. doi: 10.1016/S2214-109X(24)00150-5. Epub 2024 Jun 25.
2
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.动脉粥样硬化和心血管事件中的微塑料和纳米塑料。
N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822.
3
Air pollution exposure and cardiometabolic risk.空气污染暴露与心血管代谢风险。
Lancet Diabetes Endocrinol. 2024 Mar;12(3):196-208. doi: 10.1016/S2213-8587(23)00361-3. Epub 2024 Feb 1.
4
A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease.一种基于数据驱动的方法来解码代谢功能障碍相关脂肪性肝病。
Ann Hepatol. 2024 Mar-Apr;29(2):101278. doi: 10.1016/j.aohep.2023.101278. Epub 2023 Dec 20.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
6
Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study.2 型糖尿病和冠心病遗传易感性的代谢特征差异：一项反向孟德尔随机化研究。
EBioMedicine. 2023 Apr;90:104503. doi: 10.1016/j.ebiom.2023.104503. Epub 2023 Mar 2.
7
The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health.心血管疾病及其风险的全球负担：未来健康指南。
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. doi: 10.1016/j.jacc.2022.11.005. Epub 2022 Nov 9.
8
Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭的免疫代谢机制
Nat Cardiovasc Res. 2022 Mar;1(3):211-222. doi: 10.1038/s44161-022-00032-w. Epub 2022 Mar 14.
9
Fine particulate matter (PM) inhalation-induced alterations in the plasma lipidome as promoters of vascular inflammation and insulin resistance.细颗粒物（PM）吸入引起的血浆脂质组改变可促进血管炎症和胰岛素抵抗。
Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1836-H1850. doi: 10.1152/ajpheart.00881.2020. Epub 2021 Mar 5.
10
Machine Learning Algorithm Predicts Cardiac Resynchronization Therapy Outcomes: Lessons From the COMPANION Trial.机器学习算法预测心脏再同步治疗结局：来自 COMPANION 试验的经验。
Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005499. doi: 10.1161/CIRCEP.117.005499.
Zotero 插件